D10000: "THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY"
GS0421: research directed to the development of pharmaceuticals related to the treatment of diabetic complications, cancer, neuromuscular diseases, and other diseases
Case File Event Statements
10/29/2021 - 3 years ago
18 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type:CAEX
8/31/2009 - 15 years ago
17 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)Type:RNL1
8/31/2009 - 15 years ago
16 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDType:89AG
8/21/2009 - 15 years ago
15 - ASSIGNED TO PARALEGALType:PLGL
8/19/2009 - 15 years ago
14 - TEAS SECTION 8 & 9 RECEIVEDType:E89R
8/25/2006 - 18 years ago
13 - CASE FILE IN TICRSType:CFIT
9/27/2005 - 19 years ago
12 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A
9/26/2005 - 19 years ago
11 - ASSIGNED TO PARALEGALType:PLGL
8/23/2005 - 19 years ago
10 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILEDType:815F
8/23/2005 - 19 years ago
9 - TEAS SECTION 8 & 15 RECEIVEDType:E815
8/24/1999 - 25 years ago
8 - REGISTERED-PRINCIPAL REGISTERType:R.PR
6/1/1999 - 25 years ago
7 - PUBLISHED FOR OPPOSITIONType:PUBO
4/30/1999 - 25 years ago
6 - NOTICE OF PUBLICATIONType:NPUB
2/23/1999 - 25 years ago
5 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/5/1999 - 25 years ago
4 - EXAMINER'S AMENDMENT MAILEDType:CNEA
10/20/1998 - 26 years ago
3 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA